Goldman Sachs
ELOS

Goldman Sachs’s Syneron Medical Ltd ELOS Stock Holding History

Goldman Sachs’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-85,807
Closed -$940K – 7113
2017
Q2 		$940K Buy
85,807
+33,594
+64% +$368K ﹤0.01% 4526
2017
Q1 		$551K Buy
52,213
+16,910
+48% +$164K ﹤0.01% 4935
2016
Q4 		$297K Buy
35,303
+23,803
+207% +$187K ﹤0.01% 5493
2016
Q3 		$82K Sell
11,500
-2,989
-21% -$20.8K ﹤0.01% 6322
2016
Q2 		$111K Buy
14,489
+3,999
+38% +$28.5K ﹤0.01% 6077
2016
Q1 		$77K Sell
10,490
-822
-7% -$5.89K ﹤0.01% 6214
2015
Q4 		$87K Sell
11,312
-7,999
-41% -$61K ﹤0.01% 6260
2015
Q3 		$138K Sell
19,311
-10,074
-34% -$96.8K ﹤0.01% 6267
2015
Q2 		$312K Buy
29,385
+16,573
+129% +$194K ﹤0.01% 5703
2015
Q1 		$159K Buy
+12,812
New +$142K ﹤0.01% 6164
2013
Q3 		– Sell
-28,818
Closed -$251K – 6800
2013
Q2 		$251K Buy
+28,818
New +$258K ﹤0.01% 5440

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Goldman Sachs's ELOS Position: Q3 2017 in Review

Goldman Sachs sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 85,807 shares — an estimated $940K sold.

Goldman Sachs first reported a position in ELOS in Q2 2013 and held it in 11 quarters. The position peaked at $940K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Goldman Sachs reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Goldman Sachs sold 85,807 Syneron Medical Ltd shares in Q3 2017, an estimated $940K.
  • Goldman Sachs first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 11 quarters.
  • Goldman Sachs's Syneron Medical Ltd position peaked at $940K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Goldman Sachs's 13F filing for Q3 2017, filed 14 Nov 2017.